scispace - formally typeset
Open AccessJournal Article

Identification of hypoglycemia in mice as a surrogate marker of ricin toxicosis.

Reads0
Chats0
TLDR
Blood glucose concentration may be used as a surrogate for lethal challenge as a measure of ricin toxicosis after its systemic administration, and immunized animals had smaller changes in blood glucose concentration than did non-immunized animals after ricin administration.
Abstract
PURPOSE: In an effort to develop a non-lethal model of ricin toxicosis, we studied the biochemical effects of the administration of ricin in mice. METHODS: Mice received an intraperitoneal injection of ricin toxin, after which a panel of 21 biochemical parameters was determined. Effect of ricin administration on blood glucose concentration was studied in greater detail. To determine whether results of biochemical analyses correlated with therapeutic manipulations known to protect against ricin toxicosis, the effect of immunization on blood glucose values after ricin administration was studied. RESULTS: Of the biochemical parameters studied, only blood glucose and amylase values were affected by ricin administration. Because blood glucose concentration can be easily and instantaneously measured on 25 to 50 microl of blood, using handheld instruments, this parameter was further evaluated. A dose- and time-related decrease in blood glucose concentration was documented. Mice immunized with ricin had smaller changes in blood glucose concentration than did non-immunized animals after ricin administration. CONCLUSION: Blood glucose concentration may be used as a surrogate for lethal challenge as a measure of ricin toxicosis after its systemic administration.

read more

Citations
More filters
Journal ArticleDOI

Immunological Characteristics Associated with the Protective Efficacy of Antibodies to Ricin

TL;DR: It is demonstrated that immunization with A chain induces greater protection than Immunization with B chain, and an anti-A chain Ab is obtained that bound with high avidity, blocked enzymatic activity, did not neutralize cytotoxicity, and actually enhanced the in vivo toxicity of ricin.
Journal ArticleDOI

RiVax, a recombinant ricin subunit vaccine, protects mice against ricin delivered by gavage or aerosol.

TL;DR: The development of gavage and aerosol ricin challenge models in mice are described and it is demonstrated that i.m. vaccination protects mice against ricin delivered by either route and RiVax protects against aerosol-induced lung damage as determined by histology and lung function tests.
Journal ArticleDOI

A Monoclonal Immunoglobulin G Antibody Directed against an Immunodominant Linear Epitope on the Ricin A Chain Confers Systemic and Mucosal Immunity to Ricin

TL;DR: In this article, the authors describe the development and characterization of GD12, a murine monoclonal IgG1 antibody specifically directed against residues 163 to 174 (TLARSFIICIQM) of RTA.
Journal ArticleDOI

Stepwise engineering of heterodimeric single domain camelid VHH antibodies that passively protect mice from ricin toxin.

TL;DR: In an effort to engineer countermeasures for the category B toxin ricin, a collection of epitopic tagged, heavy chain-only antibody VH domains (VHHs) specific for the ricin enzymatic (RTA) and binding (RTB) subunits were produced and characterized.
Journal ArticleDOI

Protective immunity to ricin toxin conferred by antibodies against the toxin's binding subunit (RTB)

TL;DR: Two RTB-specific neutralizing monoclonal IgG(1) antibodies, 24B11 and SylH3, were sufficient to protect the animals against a 5×LD(50) dose of ricin, raising the possibility of using specific RTB sub-domains, rather than RTB itself, as antigens to more efficiently elicit neutralizing antibodies and protective immunity against ricin.
Related Papers (5)